Prostate cancer is the second most commonly occurring cancer in men and the fourth most commonly occurring cancer overall. There were 1.3 million new cases in 2018. The top 20 countries with the highest rates of prostate cancer in 2018 are given in the table below.
Age-adjusted incidence rates of prostate cancer have increased dramatically and this is largely because of the increased availability of screening for prostate-specific antigen (PSA) in men without symptoms of the disease. This test leads to detection of many prostate cancers that are small and/or would otherwise remain unrecognised, and which may or may not develop further into higher stage disease.
The Continuous Update Project Panel judged there is strong evidence that greater body fatness is a cause of advanced prostate cancer, and developmental factors (marked by adult attained height) are a cause of prostate cancer. There is strong evidence that beta-carotene (from food or supplements) has no substantial effect on the risk of prostate cancer.
We also fund research on prostate cancer through our regular grant programme.
Age-standardised rates are used in the tables. This is a summary measure of the rate of disease that a population would have if it had a standard age structure. Standardisation is necessary when comparing populations that differ with respect to age because age has a powerful influence on the risk of dying from cancer.
Prostate cancer rates
Guadeloupe had the highest rate of prostate cancer in 2018, followed by Martinique.
|Rank||Country||Age-standardised rate per 100,000|
|10||New Caledonia (France)||93.0|